Align Technology, Inc. (NASDAQ:ALGN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Align Technology, Inc. (NASDAQ:ALGN) have been given a consensus rating of “Moderate Buy” by the sixteen brokerages that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $215.00.

Several research firms recently weighed in on ALGN. Evercore ISI lifted their target price on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Wednesday, July 9th. Piper Sandler lowered their target price on Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a research report on Thursday, July 31st. Stifel Nicolaus lowered their target price on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a research report on Thursday, July 31st. Zacks Research downgraded Align Technology from a “hold” rating to a “strong sell” rating in a research report on Monday, September 1st. Finally, Wells Fargo & Company lowered their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a research report on Thursday, July 31st.

Insider Activity at Align Technology

In other Align Technology news, CEO Joseph M. Hogan acquired 7,576 shares of the stock in a transaction dated Friday, August 1st. The shares were acquired at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the transaction, the chief executive officer directly owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. The trade was a 4.27% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.66% of the stock is owned by insiders.

Hedge Funds Weigh In On Align Technology

Several large investors have recently made changes to their positions in ALGN. Vise Technologies Inc. purchased a new position in shares of Align Technology in the fourth quarter valued at about $202,000. GTS Securities LLC lifted its position in shares of Align Technology by 114.0% in the fourth quarter. GTS Securities LLC now owns 1,138 shares of the medical equipment provider’s stock valued at $237,000 after acquiring an additional 9,275 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Align Technology in the fourth quarter valued at about $5,572,000. Toronto Dominion Bank lifted its position in shares of Align Technology by 32.7% in the fourth quarter. Toronto Dominion Bank now owns 32,669 shares of the medical equipment provider’s stock valued at $6,812,000 after acquiring an additional 8,043 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its position in shares of Align Technology by 41.1% in the fourth quarter. Mackenzie Financial Corp now owns 9,872 shares of the medical equipment provider’s stock valued at $2,058,000 after acquiring an additional 2,877 shares in the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.

Align Technology Price Performance

Shares of ALGN opened at $124.88 on Friday. Align Technology has a one year low of $122.00 and a one year high of $259.01. The firm has a market capitalization of $9.05 billion, a P/E ratio of 21.06, a PEG ratio of 1.44 and a beta of 1.65. The business has a fifty day moving average of $148.59 and a 200 day moving average of $167.26.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm earned $2.41 EPS. The business’s revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Analysts expect that Align Technology will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has authorized a stock buyback plan on Tuesday, August 5th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to repurchase up to 2% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board believes its shares are undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.